CONCORD BIOTECH LIMITED

CONCORD BIOTECH LIMITED - IPO DETAILS 

Company Overview 

Concord Biotech Limited, established in 1984, is an Indian biopharma company driven by research and development. It is renowned as a leading global developer and manufacturer of fermentation-based APIs in immunosuppressants and oncology, holding a substantial market share based on volume in 2022. 

Concord Biotech has established a strong global presence by supplying its products to more than 70 countries, including the USA, India, Europe, and Japan. The company's expertise lies in manufacturing Active Pharmaceutical Ingredients (API) through both fermentation and semi-synthetic processes, as well as producing finished formulations. Starting with a single product, Concord Biotech has evolved into a comprehensive solution provider, offering a wide range of pharmaceutical solutions. 

Concord Biotech is engaged in the production of fermentation and semi-synthetic-based pharmaceutical products, covering various therapeutic segments such as Immunosuppressants, Anti-bacterial, Oncology, Antifungals, and others. The diverse portfolio of products has garnered significant interest from customers worldwide. Additionally, the company boasts a strong pipeline of products currently under development, promising further expansion and innovation in the future. 

Objective of the IPO 

Here are a few quick reasons why Concord Biotech Limited going public:  

1. Obtain the advantages of listing equity shares on stock exchanges. 

2. Execute the Selling Shareholder's Offer to Sell Up to 20,925,652 Equity Shares. 

Company Financials 

Key Performance Indicator 

Pros 

1. In 2022, Concord Biotech had a market share of more than 20% by volume for active APIs based on fermentation, including mupirocin. 

2. The business has a diverse worldwide clientele and keeps in touch with its most important customers throughout time. 

3. . The business is well-represented along the whole value chain of the intricate fermentation process. 

4. The business is committed to creating complex, specialised fermentation-based products with significant development poten 

Cons 

1. The business benefits from some government incentive programmes. Any modification or cessation of the use of such programmes might have an effect on the profitability of the company's operations. 

2. The business may be affected by any local, national, or international health emergency or limitation. 

3. Most of the company's revenue is derived from a small number of clients. 

4. There are several government restrictions that apply to it. 

How to Apply for this IPO 

1. Go to https://ipo.adityatrading.in/ 

2. Enter your Client ID 

3. Enter the OTP received in your registered mobile number. 

4. Choose the IPO and click on apply button. 

5. Enter the UPI ID, Quantity, and Cut off the price. 

6. Click on submit button 

7. Confirm the mandate request received on your phone by entering the UPI Pin. 

You can also watch our youtube video on “How to Apply on IPO” by clicking on the link “https://www.youtube.com/watch?v=1qOI8dCpl1I&ab_channel=ATS”